RECRUITING

Registry of Asthma Characterization and Recruitment 3 (RACR3)

Description

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

Conditions

Study Overview

Study Details

Study overview

This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

Registry of Asthma Characterization and Recruitment 3 (RACR3) (CAUSE-02)

Registry of Asthma Characterization and Recruitment 3 (RACR3)

Condition
Asthma
Intervention / Treatment

-

Contacts and Locations

Aurora

Children's Hospital Colorado: Allergy Program, Aurora, Colorado, United States, 80045

Washington

Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site, Washington, District of Columbia, United States, 20010

Chicago

Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology, Chicago, Illinois, United States, 60611

Boston

Boston Children's Hospital: Department of Immunology, Boston, Massachusetts, United States, 02215

New York

Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute, New York, New York, United States, 10029

New York

Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, New York, New York, United States, 10032

Cincinnati

Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati, Ohio, United States, 45229

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Participant is either:
  • 1. At least 18 years old, willing and able to provide informed consent at the time of enrollment
  • 2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
  • 2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)
  • 1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
  • 2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up
  • 3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

National Institute of Allergy and Infectious Diseases (NIAID),

Christine A. Sorkness, RPh, PharmD, STUDY_CHAIR, University of Wisconsin School of Medicine and Public Health; Division of Allergy & Immunology

Daniel J. Jackson, MD, STUDY_CHAIR, University of Wisconsin School of Medicine and Public Health; Division of Allergy & Immunology

Study Record Dates

2028-05